ICH Q4B Annex 5 Disintegration test

Current effective version

PDF iconAdopted guideline

Reference number CHMP/ICH/308895/08
Published 01/06/2009
Effective from 01/12/2009
Keywords Disintegration test, tablets, capsules, pharmacopoeia
Description This annex is the result of the Q4B process for Disintegration Test General Chapter. The proposed texts were submitted by the Pharmacopoeial Discussion Group. It aims to facilitate the recognition of pharmacopoeial procedures for the disintegration test by regulatory authorities in the ICH regions. It describes special requirements for this test to be considered interchangable for use in the ICH regions.

Document history

First version

Current version

PDF iconAdopted guideline


PDF iconDraft guideline

In operation: 01/12/2009–present


Published: 01/06/2008

Related content

How useful was this page?

Add your rating